A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects - Concepedia

Concepedia

Publication | Closed Access

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

54

Citations

13

References

2018

Year

Orit Cohen‐Barak, Sivan Weiss, Michèle Rasamoelisolo, Nicola Faulhaber, Paul Yeung, Pippa S. Loupe, Esther Yoon, Mohit D. Gandhi, Ofer Spiegelstein, Ernesto Aycardi

Abstract

The results of the pharmacokinetic exposure parameters and safety measures were similar for Japanese and Caucasians and support the once monthly and once quarterly sc injections of fremanezumab.

References

	Year	Citations

Page 1